MedPath

OKAYAMA UNIVERSITY

OKAYAMA UNIVERSITY logo
🇯🇵Japan
Ownership
Private
Established
1949-05-01
Employees
-
Market Cap
-
Website
http://www.okayama-u.ac.jp

Clinical Trials

183

Active:0
Completed:111

Trial Phases

4 Phases

Phase 1:7
Phase 2:10
Phase 3:6
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (174 trials with phase data)• Click on a phase to view related trials

Not Applicable
151 (86.8%)
Phase 2
10 (5.7%)
Phase 1
7 (4.0%)
Phase 3
6 (3.4%)

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Phase 2
Recruiting
Conditions
Triple Negative Breast Neoplasms
Triple Negative Breast Cancer
Breast Neoplasms
Breast Cancer
BRCA1 Mutation
BRCA2 Mutation
BRCA Mutation
BRCA-Associated Breast Carcinoma
Interventions
First Posted Date
2022-08-03
Last Posted Date
2025-03-20
Lead Sponsor
Okayama University
Target Recruit Count
23
Registration Number
NCT05485766
Locations
🇯🇵

Gifu University Hospital, Gifu, Japan

🇯🇵

Okayama University Hospital, Okayama, Japan

🇯🇵

St. Luke's International Hospital, Tokyo, Japan

Effectiveness of Exercises in Patient With Diabetic Peripheral Neuropathy

Not Applicable
Completed
Conditions
Diabetic Peripheral Neuropathy
First Posted Date
2018-03-01
Last Posted Date
2019-05-10
Lead Sponsor
Okayama University
Target Recruit Count
121
Registration Number
NCT03450200
Locations
🇯🇵

Okayama University, Okayama, Japan

Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes

Completed
Conditions
Activities of Daily Living
Diabetic Neuropathy Peripheral
First Posted Date
2018-02-22
Last Posted Date
2019-05-10
Lead Sponsor
Okayama University
Target Recruit Count
975
Registration Number
NCT03440203
Locations
🇯🇵

Okayama University, Okayama, Japan

Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy

Phase 1
Completed
Conditions
Dilated Cardiomyopathy
First Posted Date
2017-04-26
Last Posted Date
2021-11-26
Lead Sponsor
Okayama University
Target Recruit Count
5
Registration Number
NCT03129568
Locations
🇯🇵

Okayama University Hospital, Okayama, Japan

Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services

Completed
Conditions
Atherosclerosis
Periodontal Disease
First Posted Date
2013-05-31
Last Posted Date
2013-05-31
Lead Sponsor
Okayama University
Target Recruit Count
116
Registration Number
NCT01866761
Locations
🇯🇵

Okayama University of Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

Japanese Study Shows 81% Success Rate for PFO Closure in Drug-Resistant Migraine Patients

A Japanese study of 27 patients with drug-resistant migraine found that 81% experienced significant improvement or complete resolution after transcatheter patent foramen ovale closure at 12 months.

Anti-PD-1 Autoantibody Levels Predict Survival in Liver Cancer Patients Treated with Atezolizumab and Bevacizumab

Researchers found that higher levels of anti-PD-1 autoantibodies in blood serum correlate with lower survival rates in HCC patients undergoing Atezolizumab/Bevacizumab therapy.

© Copyright 2025. All Rights Reserved by MedPath